Partner Headlines - MDCO

  1. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. Benzinga's Top Downgrades

    Benzinga
  4. Medicines Co.

    IBD
  5. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  6. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  7. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  8. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  9. Stocks Hitting 52-Week Lows

    Benzinga
  10. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  11. Morning Market Losers

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Medicines Co. earnings miss

    IBD
  14. Earnings Scheduled For February 19, 2014

    Benzinga
  15. FDA nixes Medicines' drug

    IBD
  16. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  17. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  18. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  19. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  20. Stocks Hitting 52-Week Lows

    Benzinga
  21. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  24. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  25. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  26. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  27. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  28. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  29. Medicines acquires Rempex

    IBD
  30. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  31. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  32. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  33. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  34. A Few Stocks Form Bases, But Have Flaws

    IBD
  35. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  36. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  37. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  38. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  39. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  40. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  41. Medicines Co. In Late Stages Of Base Formation

    IBD
  42. Medicines Co. sales topped

    IBD
  43. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  44. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  45. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  46. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  47. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  48. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  49. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  50. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  51. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  52. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  53. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  54. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  55. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  56. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  57. A Peek Into The Market Before The Trading Starts

    Benzinga
  58. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  59. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  60. 3D Systems Leads Top 5 Small Caps Despite Stock Slide

    IBD
  61. Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD

    GuruFocus
  62. Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS

    GuruFocus
  63. Medicines (MDCO) President & CFO Glenn Sblendorio sells 125, ...

    GuruFocus
  64. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 2,500 Shares

    GuruFocus
  65. Small Cap Leaders: 3D Systems, IXIA Lead Top 5 Stocks

    IBD
  66. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  67. Medicines (MDCO) President & CFO Glenn Sblendorio sells 25,0 ...

    GuruFocus
  68. 5 Key Stock Moves From JPMorgan Health Care Confab

    IBD
  69. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, ...

    Benzinga
  70. Eylea Sales Hurt Regeneron

    IBD
  71. Mid-Afternoon Market Update: Markets Fall Further, Isis Pharma ...

    Benzinga
  72. Medtech Stocks Moving As Conference Makes Waves

    IBD
  73. Medtech Stocks Moving As Conference Makes Waves

    IBD
  74. Mid-Day Market Update: Markets Remain Down, The Medicines Company ...

    Benzinga
  75. The Medicines Co. Offers Results of Phase 3 Trial of Cangrelor ...

    Benzinga
  76. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 5,000 Shares

    GuruFocus
  77. Cadence Pharmaceuticals Terminates Option Agreement to Acquire ...

    Benzinga
  78. Medicines Company to Acquire Incline Therapeutics

    Benzinga
  79. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 13,593 Shares

    GuruFocus
  80. Medicines Company Reports Operating Results (10-Q)

    GuruFocus
  81. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 13,600 Shares

    GuruFocus
  82. UPDATE: Jefferies Upgrades The Medicines Company to Buy on Attractive ...

    Benzinga
  83. The Medicines Company Stops Phase 2b Trial of MDCO-2010

    Benzinga
  84. Annovation Biopharma Raises $8M to Develop Novel Anesthetics

    Benzinga
  85. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  86. UPDATE: Bank of America Initiates Neutral, $29 PO on The Medicines ...

    Benzinga
  87. Medicines Company (MDCO) President & CFO Glenn Sblendorio sells ...

    GuruFocus
  88. Medicines Company (MDCO) President & CFO Glenn Sblendorio sells ...

    GuruFocus
  89. The Medicines Co.

    IBD
  90. Health Care Sector Wrap

    FoxBusiness
  91. AOL, The Medicines Company, Other Stocks Hit 52-Week Highs Wednesday

    FoxBusiness
  92. Altera, Symantec Among Stocks Gapping Up Wednesday

    FoxBusiness
  93. American Capital Agency, Dollar General Among Stocks Setting ...

    FoxBusiness
  94. Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells ...

    GuruFocus
  95. The Medicines Company Announces Intention to Offer $200 Million ...

    Benzinga
  96. Medicines Company (MDCO) Executive VP & CFO Glenn Sblendorio ...

    GuruFocus
  97. Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells ...

    GuruFocus
  98. UPDATE: Auriga Raises Price Target on the Medicines Company to ...

    Benzinga
  99. Medicines Co. Q4 tops views

    IBD
  100. Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells ...

    GuruFocus
Trading Center